Indication

Diabetic gastroparesis

Diabetic gastroparesis is a chronic neuromuscular complication of diabetes mellitus characterized by objectively delayed gastric emptying in the absence of mechanical gastric outlet obstruction. Read more about Diabetic gastroparesis

44 drugs 39 manufacturers

Advertisement

Drugs that treat it

Common Diabetic gastroparesis therapies.

Showing 37–44 of 44 drugs

METOCLOPRAMIDE HCL

ANTIEMETIC·GASTROINTESTINAL RADIOGRAPHY ADJUNCT·+4
Avet Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Diabetic gastroparesis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Diabetic gastroparesis.

Diabetic gastroparesis is a chronic neuromuscular complication of diabetes mellitus characterized by objectively delayed gastric emptying in the absence of mechanical gastric outlet obstruction.

Primarily affecting the gastrointestinal system in individuals with type 1 or type 2 diabetes, the disorder stems from autonomic neuropathy, enteric nerve damage, and loss of interstitial cells of Cajal, often exacerbated by chronic hyperglycemia.

Patients typically present with upper gastrointestinal symptoms including persistent nausea, vomiting, early satiety, postprandial fullness, abdominal bloating, and epigastric pain.

The resulting erratic transit of nutrients frequently causes unpredictable glucose absorption, leading to severe glycemic instability and nutritional compromise.

Personalize your experience

Follow Diabetic gastroparesis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it